PhRMA, A Congresswoman And A Flap Over Campaign Finance Rules

esilverman Did a congresswoman violate campaign laws by enlisting campaign help from PhRMA? That question is being asked after a senior aide to Colleen Hanabusa, a Democrat ...

Sanofi, NEA team up in $18M round for rare disease outfit Edimer

Ryan McBride Edimer aims to use the new funds to bankroll a midstage study of its lead candidate EDI200, a recombinant protein intended to restore normal development in newborns with ...

Sanofi’s bid for more OTC meds gets FDA boost

Tracy Staton Sanofi may soon have a another allergy drug to add to its over-the-counter stable. FDA reviewers backed Nasacort AQ as safe for use without a prescription Reuters reports, ...

Fighting Cancer May Be Harder As Many Drug Trials Are Undisclosedhed

esilverman To disclose or not to disclose? Shakespearean allusions aside, there is little question that drugmakers and researchers are under increasing pressure to comply with ...

Valeant to Cut Jobs, Move Bausch + Lomb HQ

barbara.lempert NEW YORK (AP) — Valeant says it will eliminate as much as 15 percent of its work force and move Bausch + Lomb’s headquarters to New Jersey as part of ...

BioClinica Appoints New EVP and President for Imaging Core Lab Division

mia.burns David S. Herron Joins BioClinica to Lead Imaging Core Lab Division – Heads World’s Largest, Most Experienced Imaging Core Lab Operations – NEWTOWN, PA, July ...

BioClinica appoints new leader for Imaging Core Lab Division

mia.burns Clinical trial management services provider BioClinica has appointed David S. Herron to the position of EVP and president of the company’s Imaging Core Lab Division. Herron ...

Class-Action Suit Against Pfizer Over Anti-Smoking Drug Champix Will Proceed

barbara.lempert OTTAWA, Canada, July 26, 2013 (CANADIAN PRESS DATAFILE) – A class-action lawsuit against pharmaceutical giant Pfizer Canada over its anti-smoking drug ...

Court overturns patents on Teva’s MS drug Copaxone

barbara.lempert NEW YORK, July 26, 2013 (AP) — Two drug companies said Friday that they hope to start selling a generic version of the multiple sclerosis treatment Copaxone ...

Earnings Preview: Pfizer to report on new drugs

barbara.lempert Earnings Preview: Pfizer to report on new drugs TRENTON, N.J., July 26, 2013 (AP) — Pfizer Inc. will update analysts on progress on its experimental drugs, particularly ...

Teva gets exclusive rights for OTC morning-after pill

barbara.lempert Teva gets exclusive rights for OTC morning-after pill PHILADELPHIA, July 26, 2013 (PHILADELPHIA INQUIRER)–The morning-after pill debate began anew this week when ...

Perrigo to buy Elan for $8.6B, seeks tax savings

barbara.lempert DUBLIN, July 29, 2013 (AP) — U.S. drugmaker Perrigo has agreed to buy Ireland’s Elan for $ 8.6 billion in a deal designed to expand overseas and reduce ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS